The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Transformation to pure-play Innovative Medicines company nears completion
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
SK Capital’s investment will serve as a catalyst for a new strategic direction as the Company seeks to deepen and expand its presence in fine chemistries for the global life science market.
Two main objectives are: Accelerate novel technologies and products for global markets; and Connect academia and industry, creating synergy for faster advancement of the Bioprotection sector
Subscribe To Our Newsletter & Stay Updated
